List of Lab Research Products Companies in Taiwan - 4

Abnova is the first biotech company successfully integrated the IT-style management and industrial-scale antibody manufacturing. Our goal is to have at least one antibody to every human expressed gene in human genome. In Phase I of our business plans, we vastly expand the scope and availability of antibody reagents for the research market by taking a genome-wide approach to the high throughput production of human protein and antibody. There products are marketed through a combination of E-commerce based direct sales and a multi-tiered, sales network of over 49 distributors around the world. Starting from Year 2009 to 2013, in Phase II of the business plans, we have diversified into the systems arena focusing on antibody pairs, ELISA kits and instrumentation for rare cell isolation. In Phase III, we focus on in vitro diagnostics development concentrating on non-invasive, liquid biopsies of circulating tumor cells, ctDNA, and exosomes for precision medicine. Now in Phase IV (Year 2017 and later), we have focused on drug development specializing on immunotherapy. The value-added business has set the path of company's future growth and provided opportunity for Abnova to contribute to the biotech industry at large. We welcome researchers, biotech, and pharmaceutical companies to work with us and succeed together!

ACRO Biomedical was founded in June 2014 in Kaohsiung, Taiwan, by Dr. Dar-Jen Hsieh and a group of scientists and physicians. ACRO Biomedical develops and produces biomaterial medical devices for human tissue engineering and regenerative medicine (TERM). ACRO Biomedical uses its proprietary supercritical CO₂ extraction technology to remove cells, fat and non-collagenous proteins from animal tissues, while keeping the undiminished collagen scaffold as the biomaterial for high-end medical devices in the medical regenerative field of wound care, orthopedics, dentistry, ophthalmology, aesthetic microsurgery, cardiovascular and neural surgery, etc.

Since 2014, Advanced Biomed Inc. has been focusing on the integration of multiple interdisciplinary technologies and established its own microfluidic technology platform. The Company aims to provide rapid and affordable assay products and services to cancer patients. The Company has a range of innovative devices, including A+Pre, AC-1000, A+CellScan, and A+SCDrop, along with three corresponding biochips: A+Pre Chip, AC-1000 CTC Enrichment Chip, and A+CellScan Chip. The Company’s technologies and products can be used for early screening and detection, diagnosis and staging, and treatment of cancer through the detection of circulating tumor cells and related tumor markers in blood samples, capture of single circulating tumor cells, and single-cell sorting and determination. Additionally, the Company has completed the research and development stage for four matching immunostaining kits, A+CTCE, A+CTCM, A+EMT, and A+CM, utilizing multiplexed staining with fluorescent-labeled antibodies to identify tumor cell types. The Company has also introduced A+LCGuard, a product designed for early screening of lung cancer to assist in the determination of benign and malignant pulmonary nodules. With the Company's primary operations, design, and development based in Taiwan, Advanced Biomed is expanding in China while preparing for the establishment of operation centers in North America and Europe.

Genomics Bioscience and Technology Co., Ltd. is Taiwan's leading commercial genome sequencing company. Our diverse services encompass comprehensive gene sequencing technology and applications and oligonucleotide and peptide synthesis, meeting standards from RUO to GMP compliance. Committed to excellence, we collaborate with prestigious academic institutions and biotech companies to advance precise medical genetic testing and champion personalized precision medicine. With over 20 years of expertise and academic experience in the biotechnology field, we are equipped with state-of-the-art technology, including the Illumina Novaseq X Plus. We offer a comprehensive NGS workflow from sample preparation to bioinformatics analysis. Our dedicated goal is to support our partners in advancing Taiwan's biotechnology sector onto the international stage and highlighting the robust strength of Taiwan's biological sciences to the world. With Taiwan as our home base, we are set to make strides on the global stage.